Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Singapore Exchange ( (SG:S68) ) has shared an update.
UltraGreen.ai Limited has successfully listed on the SGX Mainboard, marking a significant milestone in the company’s growth and its role in advancing fluorescence-guided surgery. The listing is expected to enhance UltraGreen.ai’s ability to expand its market reach and accelerate commercial execution, reflecting the growing recognition of fluorescence-guided surgery’s impact on surgical precision. This development also underscores the strength of Singapore’s MedTech sector, which continues to attract innovative healthcare technology companies.
The most recent analyst rating on (SG:S68) stock is a Buy with a S$20.00 price target. To see the full list of analyst forecasts on Singapore Exchange stock, see the SG:S68 Stock Forecast page.
More about Singapore Exchange
UltraGreen.ai is a global leader in the fluorescence-guided surgery (FGS) industry, known for pioneering AI tools for precision surgery using data-driven fluorescence imaging solutions. Their flagship product, Indocyanine Green (ICG), marketed as IC-GREEN® in the U.S. and Verdye outside North America, is widely used in FGS. The company is focused on expanding its presence in Asia and continues to invest in product development, clinical validation, and strategic growth in the global healthcare market.
Average Trading Volume: 2,538,435
Technical Sentiment Signal: Buy
Current Market Cap: S$17.99B
Learn more about S68 stock on TipRanks’ Stock Analysis page.